Brief: Celltrion Seeks To Get EMA's Approval For Its Covid-19 Treatment's Formal Use
05/10/2021 24:14
Oct 5 (Reuters) -
* CELLTRION: SEEKS TO GET EMA'S APPROVAL FOR ITS COVID-19
TREATMENT'S FORMAL USE
Source text for Eikon: https://bit.ly/2ZQNQlz
Further company coverage: 068270.KS
((Heekyong.Yang@thomsonreuters.com;))
Recent news on Celltrion
See all newsBrief: Celltrion Inc To Acquire 100 Billion Won Worth Of Own Shares
Brief: Celltrion Q1 Operating. Profit 322 Billion Won, Up 115% Y/Y
Brief: Celltrion To Cancel 100 Billion Won Treasury Shares
Brief: Celltrion Plans Phase 3 Clinical Trials For Keytruda Biosimilar With 220 Patients
Brief: Celltrion To Buy 100 Billion Won Of Own Shares